Skip to main content

Table 2 Number of lawsuits involving the 20 most requested medicines, São Paulo, 2010–2014

From: Legal access to medications: a threat to Brazil’s public health system?

Item

Number (%)

Insulin glargine - vial/cartridge/disposable pen

3539 (6.3)

Insulin aspart - vial/cartridge/disposable pen

1849 (3.3)

Methylphenidate - capsule/extended-release tablet

1773 (3.1)

Ranibizumab - ampoule

1710 (3.0)

Insulin lispro - vial/cartridge/disposable pen

1565 (2.8)

Acetylsalicylic acid (100–325 mg) - tablet/coated tablet/slow-release tablet

1309 (2.3)

Clopidogrel - tablet

1224 (2.2)

Levothyroxine (38–200 mcg) - tablet

966 (1.7)

Glucosamine + chondroitin - sachet/tablet

968 (1.7)

Cinacalcet hydrochloride - coated tablet

906 (1.6)

Boceprevir 200 mg - gelatine capsule

844 (1.5)

Simvastatin (5–80 mg) - tablet

842 (1.5)

Insulin detemir - cartridge/disposable pen

834 (1.5)

Omeprazole - tablet/capsule

799 (1.4)

Insulin glulisine - vial/cartridge/disposable pen

801 (1.4)

Sodium hyaluronate - injectable solution/vial

771 (1.4)

Pregabalin - capsule

761 (1.4)

Metformin + vildagliptin - capsule

733 (1.3)

Rosuvastatin (5–40 mg) - tablet

730 (1.3)

Zoledronic acid - injectable solution/vial

675 (1.2)

Subtotal:

23,559 (41.9)

TOTAL

56,345 (100)

  1. Source: S-Codes